$1.53 Billion is the total value of Camber Capital Management LP's 41 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 41.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | Buy | SPDR S&P 500 ETF TRput | $293,580,000 | +25.6% | 1,500,000 | +20.0% | 19.24% | +5.0% |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTD | $91,735,000 | +5.2% | 1,750,000 | +6.1% | 6.01% | -12.0% |
| V107SC | Sell | WELLPOINT INC | $75,327,000 | -5.4% | 700,000 | -12.5% | 4.94% | -20.9% |
| DGX | QUEST DIAGNOSTICS INC | $64,559,000 | +1.3% | 1,100,000 | 0.0% | 4.23% | -15.3% | |
| CYH | Buy | COMMUNITY BK SHS IND INC | $62,969,000 | +28.6% | 1,387,900 | +11.0% | 4.13% | +7.5% |
| CNMD | CONMED CORP | $61,148,000 | +1.6% | 1,385,000 | 0.0% | 4.01% | -15.0% | |
| 5100PS | Buy | VOLCANO CORPORATION | $55,471,000 | +14.9% | 3,150,000 | +28.6% | 3.64% | -3.9% |
| MYL | Buy | MYLAN INC | $51,560,000 | +322.4% | 1,000,000 | +300.0% | 3.38% | +253.0% |
| HCA | Buy | HCA HOLDINGS INC | $50,742,000 | +20.8% | 900,000 | +12.5% | 3.32% | +1.0% |
| GHDX | Buy | GENOMIC HEALTH INC | $47,265,000 | +139.3% | 1,725,000 | +130.0% | 3.10% | +100.1% |
| KERX | Buy | KERYX BIOPHARMACEUTICALS INC | $46,140,000 | +116.6% | 3,000,000 | +140.0% | 3.02% | +81.1% |
| ACHN | New | ACHILLION PHARMACEUTICALS IN | $43,906,000 | – | 5,800,000 | +100.0% | 2.88% | – |
| MASI | Buy | MASIMO CORP | $42,952,000 | +23.4% | 1,820,000 | +42.7% | 2.81% | +3.1% |
| THC | Sell | TENET HEALTHCARE CORP | $42,246,000 | -42.0% | 900,000 | -47.1% | 2.77% | -51.5% |
| LH | Buy | LABORATORY CORP AMER HLDGS | $40,960,000 | +11.2% | 400,000 | +6.7% | 2.68% | -7.0% |
| HRC | Buy | HILL ROM HLDGS INC | $37,078,000 | +60.3% | 893,223 | +48.9% | 2.43% | +34.1% |
| HAE | Sell | HAEMONETICS CORP | $35,280,000 | -9.9% | 1,000,000 | -16.8% | 2.31% | -24.7% |
| UAM | UNIVERSAL AMERN CORP NEW | $34,805,000 | +17.8% | 4,178,259 | 0.0% | 2.28% | -1.5% | |
| ARIA | Buy | ARIAD PHARMACEUTICALS INC | $31,850,000 | +31.7% | 5,000,000 | +66.7% | 2.09% | +10.1% |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDcall | $26,210,000 | – | 500,000 | +100.0% | 1.72% | – |
| BLUE | Sell | BLUEBIRD BIO INC | $25,337,000 | +57.6% | 656,900 | -7.1% | 1.66% | +31.7% |
| SQNM | Buy | SEQUENOM INC | $24,381,000 | +241.8% | 6,300,000 | +116.4% | 1.60% | +185.9% |
| NVAX | Buy | NOVAVAX INC | $21,945,000 | +115.3% | 4,750,000 | +111.1% | 1.44% | +80.0% |
| RVNC | Buy | REVANCE THERAPEUTICS INC | $21,420,000 | +126.7% | 630,000 | +110.0% | 1.40% | +89.5% |
| FURX | Buy | FURIEX PHARMACEUTICALS INC | $21,236,000 | +62.7% | 200,000 | +33.3% | 1.39% | +36.0% |
| AMRN | AMARIN CORP PLCadr | $19,360,000 | -2.8% | 11,000,000 | 0.0% | 1.27% | -18.7% | |
| WW | New | WEIGHT WATCHERS INTL INC NEW | $17,144,000 | – | 850,000 | +100.0% | 1.12% | – |
| ICUI | New | ICU MED INC | $16,880,000 | – | 277,583 | +100.0% | 1.11% | – |
| BRLI | New | BIO-REFERENCE LABS INC | $16,431,000 | – | 543,724 | +100.0% | 1.08% | – |
| GERN | Buy | GERON CORP | $16,050,000 | +63.4% | 5,000,000 | +6.4% | 1.05% | +36.6% |
| TRNX | Sell | TORNIER N V | $13,412,000 | +3.0% | 573,655 | -6.5% | 0.88% | -13.9% |
| GNMK | GENMARK DIAGNOSTICS INC | $12,287,000 | +36.1% | 908,100 | 0.0% | 0.80% | +13.9% | |
| BRKR | New | BRUKER CORP | $12,135,000 | – | 500,000 | +100.0% | 0.80% | – |
| CRDC | New | CARDICA INC | $9,547,000 | – | 8,374,846 | +100.0% | 0.63% | – |
| PLX | PROTALIX BIOTHERAPEUTICS INC | $7,300,000 | -20.3% | 2,000,000 | 0.0% | 0.48% | -33.4% | |
| TRGT | TARGACEPT INC | $7,036,000 | -5.0% | 1,560,000 | 0.0% | 0.46% | -20.7% | |
| RPRX | New | REPROS THERAPEUTICS INC | $6,753,000 | – | 390,370 | +100.0% | 0.44% | – |
| ANGO | Sell | ANGIODYNAMICS INC | $6,265,000 | -3.4% | 383,630 | -6.9% | 0.41% | -19.1% |
| BIOL | BIOLASE INC | $5,973,000 | -8.7% | 2,715,119 | 0.0% | 0.39% | -23.8% | |
| CCRN | Buy | CROSS CTRY HEALTHCARE INC | $5,202,000 | +108.9% | 797,842 | +158.6% | 0.34% | +74.9% |
| OFIX | New | ORTHOFIX INTL N V | $4,302,000 | – | 118,683 | +100.0% | 0.28% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -400,000 | -100.0% | -0.36% | – |
| NXTM | Exit | NXSTAGE MEDICAL INC | $0 | – | -820,535 | -100.0% | -0.82% | – |
| HUM | Exit | HUMANA INC | $0 | – | -200,000 | -100.0% | -1.77% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -600,000 | -100.0% | -1.81% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -300,000 | -100.0% | -1.93% | – |
| HOLX | Exit | HOLOGIC INC | $0 | – | -1,500,000 | -100.0% | -2.53% | – |
| MNKKQ | Exit | MALLINCKRODT PUB LTD CO | $0 | – | -650,000 | -100.0% | -3.23% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICALS INDS LTD | 34 | Q3 2023 | 9.7% |
| BROOKDALE SR LIVING INC | 32 | Q3 2023 | 5.0% |
| PERRIGO CO PLC | 29 | Q3 2023 | 7.1% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 8.5% |
| NEKTAR THERAPEUTICS | 28 | Q1 2022 | 9.8% |
| UNIVERSAL HLTH SVCS INC | 25 | Q3 2023 | 9.9% |
| MYRIAD GENETICS INC | 24 | Q3 2023 | 5.0% |
| SAREPTA THERAPEUTICS INC | 23 | Q3 2023 | 6.0% |
| MYLAN NV | 21 | Q3 2020 | 10.1% |
| AMAG PHARMACEUTICALS INC | 21 | Q3 2020 | 4.0% |
View Camber Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC | February 02, 2023 | ? | ? |
| Solid Biosciences Inc. | December 12, 2022 | ? | ? |
| AVROBIO, Inc. | February 14, 2022 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2022 | ? | ? |
| AMAG PHARMACEUTICALS, INC. | February 16, 2021 | ? | ? |
| Atara Biotherapeutics, Inc. | February 16, 2021 | ? | ? |
| Change Healthcare Inc. | February 16, 2021 | ? | ? |
| GLYCOMIMETICS INC | February 16, 2021 | ? | ? |
| Clovis Oncology, Inc. | February 14, 2020 | ? | ? |
| Cyclerion Therapeutics, Inc. | February 14, 2020 | ? | ? |
View Camber Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-30 |
| 13F-HR | 2023-08-14 |
View Camber Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.